Congenital myasthenic syndrome (CMS): RAPSN

Evidence-based neurology checklist on congenital myasthenic syndrome (cms): rapsn: Genetics and pathology This results from Rapsyn deficiency The causative mutations are on chromosome 11p It is a post synaptic disorder It causes acetylcholine receptor deficiency Onset Clinical features Treatment

Genetics and pathology

  • This results from Rapsyn deficiency
  • The causative mutations are on chromosome 11p
  • It is a post synaptic disorder
  • It causes acetylcholine receptor deficiency

Onset

Clinical features

Treatment

References

  1. Spillane J, Beeson DJ, Kullmann DM. Myasthenia and related disorders of the neuromuscular junction. JNNP 2010; 81:850-857.
  2. Finlayson S, Beeson D, Palace J. Congenital myasthenic syndrome: an update. Pract Neurol 2013; 13:80-91.
  3. Muller JS, Abicht A, Burke G, et al. The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder. J Med Genet 2004; 41:e104.
  4. Beeson D. Congenital myasthenic syndromes. ACNR 2005; 4:12-13.
  5. Garg N, Yiannikas C, Hardy TA, et al. Late presentations of congenital myasthenic syndromes: how many do we miss? Muscle Nerve 2016; 54:721-727. 
  6. And 1 more. Subscribe to see the full list

Related checklists

Loading...